United States Biotechnology & Medical Research

Bicara Therapeutics Inc (BCAX)

Track

Over the last 90 days, Bicara Therapeutics Inc. has seen significant insider selling activity, with a total sell value exceeding $6.9 million. No insider buying was recorded. Notable transactions include large proposed sales by Lara Meisner, Ivan Hyep, Claire Mazumdar, and Ryan Cohlhepp, primarily in May 2026. The company's stock has experienced an 11.8% increase over the same period.

Not featured in screeners

Featured in screeners

Not featured in screeners

Stock chart

Ticker: BCAX Exchange: NMS

Subscribe to get access to the transaction volume chart and in-chart transaction details

• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings

Top insiders

Company data & Insiders

Subscribe to get access to the company description and key fundamental data (market cap, shares outstanding, dividend yield, % of shares held by insiders and more)

Download results Settings

Trades

DAVID RABEN

Officer

1 sale — total 100,000 USD

Proposed sale 25 Jun 2026

Value US$3,741,156.73 | Price 51.92 | Shares 81,443

Meisner Lara

Former Chief Legal Officer

1 sale — total 1,473,716 USD

Proposed sale 1 Jun 2026

Value US$3,500,363.82 | Price 167.27 | Shares 64,736

Raben David

Officer

1 sale — total 120,010 USD

Proposed sale 26 May 2026

Value US$120,010.00 | Price 21.82 | Shares 5,500

Hyep Ivan

Chief Financial Officer

2 sales — total 375,767 USD

Planned sale 21 May 2026

Value US$187,883.32 | Price 20.42 | Shares 9,200

Proposed sale 21 May 2026

Value US$187,883.32 | Price 20.42 | Shares 9,200

Mazumdar Claire

Chief Executive Officer

4 sales — total 928,179 USD

Planned sale 18 May 2026

Value US$60,596.64 | Price 20.35 | Shares 2,978

Planned sale 18 May 2026

Value US$239,981.96 | Price 19.96 | Shares 12,022

Proposed sale 18 May 2026

Value US$313,800.00 | Price 20.92 | Shares 15,000

Proposed sale 18 May 2026

Value US$313,800.00 | Price 20.92 | Shares 15,000

Cohlhepp Ryan

President and COO

3 sales — total 507,524 USD

Planned sale 15 May 2026

Value US$91,313.55 | Price 20.29 | Shares 4,500

Planned sale 15 May 2026

Value US$162,335.20 | Price 20.29 | Shares 8,000

Proposed sale 15 May 2026

Value US$253,875.00 | Price 20.31 | Shares 12,500

Raben David

Chief Medical Officer

2 sales — total 251,660 USD

Planned sale 27 Apr 2026

Value US$125,830.10 | Price 22.88 | Shares 5,500

Proposed sale 27 Apr 2026

Value US$125,830.01 | Price 22.88 | Shares 5,500

Hyep Ivan

Chief Financial Officer

2 sales — total 424,824 USD

Planned sale 21 Apr 2026

Value US$211,613.80 | Price 23.00 | Shares 9,200

Proposed sale 21 Apr 2026

Value US$213,210.00 | Price 23.18 | Shares 9,200

Mazumdar Claire

Chief Executive Officer

2 sales — total 710,246 USD

Planned sale 20 Apr 2026

Value US$354,145.50 | Price 23.61 | Shares 15,000

Proposed sale 20 Apr 2026

Value US$356,100.00 | Price 23.74 | Shares 15,000

Cohlhepp Ryan

President and COO

3 sales — total 574,841 USD

Planned sale 15 Apr 2026

Value US$103,532.85 | Price 23.01 | Shares 4,500

Planned sale 15 Apr 2026

Value US$184,058.40 | Price 23.01 | Shares 8,000

Proposed sale 15 Apr 2026

Value US$287,250.00 | Price 22.98 | Shares 12,500

Raben David

Chief Medical Officer

2 sales — total 208,459 USD

Planned sale 25 Mar 2026

Value US$104,229.40 | Price 18.95 | Shares 5,500

Proposed sale 25 Mar 2026

Value US$104,229.40 | Price 18.95 | Shares 5,500

Hyep Ivan

Chief Financial Officer

2 sales — total 341,468 USD

Planned sale 23 Mar 2026

Value US$170,348.12 | Price 18.52 | Shares 9,200

Proposed sale 23 Mar 2026

Value US$171,120.00 | Price 18.60 | Shares 9,200

Mazumdar Claire

Chief Executive Officer

2 sales — total 60,493 USD

Planned sale 20 Mar 2026

Value US$30,246.27 | Price 18.95 | Shares 1,596

Proposed sale 20 Mar 2026

Value US$30,246.27 | Price 18.95 | Shares 1,596

Mazumdar Claire

Chief Executive Officer

2 sales — total 259,410 USD

Planned sale 19 Mar 2026

Value US$129,704.90 | Price 18.78 | Shares 6,905

Proposed sale 19 Mar 2026

Value US$129,704.90 | Price 18.78 | Shares 6,905

Mazumdar Claire

Chief Executive Officer

2 sales — total 247,130 USD

Planned sale 18 Mar 2026

Value US$122,414.51 | Price 18.84 | Shares 6,499

Proposed sale 18 Mar 2026

Value US$124,715.81 | Price 19.19 | Shares 6,499

Cohlhepp Ryan

President and COO

3 sales — total 487,464 USD

Planned sale 16 Mar 2026

Value US$88,456.95 | Price 19.66 | Shares 4,500

Planned sale 16 Mar 2026

Value US$157,256.80 | Price 19.66 | Shares 8,000

Proposed sale 16 Mar 2026

Value US$241,750.00 | Price 19.34 | Shares 12,500

Mazumdar Claire

Chief Executive Officer

2 sales — total 1,409,314 USD

Planned sale 9 Mar 2026

Value US$704,657.16 | Price 19.17 | Shares 36,766

Proposed sale 9 Mar 2026

Value US$704,657.15 | Price 19.17 | Shares 36,766

Mazumdar Claire

Chief Executive Officer

2 sales — total 147,144 USD

Planned sale 6 Mar 2026

Value US$71,571.80 | Price 18.75 | Shares 3,817

Proposed sale 6 Mar 2026

Value US$75,571.80 | Price 19.80 | Shares 3,817

Mazumdar Claire

Chief Executive Officer

2 sales — total 66,928 USD

Planned sale 5 Mar 2026

Value US$33,464.10 | Price 18.74 | Shares 1,786

Proposed sale 5 Mar 2026

Value US$33,464.10 | Price 18.74 | Shares 1,786

Mazumdar Claire

Chief Executive Officer

2 sales — total 98,577 USD

Planned sale 4 Mar 2026

Value US$49,288.63 | Price 18.73 | Shares 2,631

Proposed sale 4 Mar 2026

Value US$49,288.62 | Price 18.73 | Shares 2,631

Hyep Ivan

Chief Financial Officer

2 sales — total 108,123 USD

Planned sale 4 Mar 2026

Value US$54,061.71 | Price 18.25 | Shares 2,963

Proposed sale 4 Mar 2026

Value US$54,061.71 | Price 18.25 | Shares 2,963

Raben David

Chief Medical Officer

2 sales — total 603,840 USD

Planned sale 4 Mar 2026

Value US$301,920.01 | Price 18.52 | Shares 16,300

Proposed sale 4 Mar 2026

Value US$301,920.01 | Price 18.52 | Shares 16,300

Cohlhepp Ryan

President and COO

3 sales — total 631,785 USD

Planned sale 3 Mar 2026

Value US$81,733.95 | Price 18.16 | Shares 4,500

Planned sale 3 Mar 2026

Value US$234,158.69 | Price 18.16 | Shares 12,892

Proposed sale 3 Mar 2026

Value US$315,892.63 | Price 18.16 | Shares 17,392

Hyep Ivan

Chief Financial Officer

2 sales — total 493,819 USD

Planned sale 3 Mar 2026

Value US$246,909.75 | Price 18.22 | Shares 13,555

Proposed sale 3 Mar 2026

Value US$246,909.75 | Price 18.22 | Shares 13,555

Raben David

Chief Medical Officer

2 sales — total 7,380 USD

Planned sale 3 Mar 2026

Value US$3,690.00 | Price 18.45 | Shares 200

Proposed sale 3 Mar 2026

Value US$3,690.00 | Price 18.45 | Shares 200

RA CAPITAL MANAGEMENT, L.P.

1 purchase — total 4,800,000 USD

Buy 26 Feb 2026

Value US$4,800,000.00 | Price 16.00 | Shares 300,000

Cohlhepp Ryan

President and COO

3 sales — total 131,003 USD

Planned sale 25 Feb 2026

Value US$9,434.66 | Price 18.04 | Shares 523

Planned sale 25 Feb 2026

Value US$56,066.77 | Price 18.04 | Shares 3,108

Proposed sale 25 Feb 2026

Value US$65,501.42 | Price 18.04 | Shares 3,631

Cohlhepp Ryan

President and COO

2 sales — total 134,257 USD

Planned sale 22 Jan 2026

Value US$69,295.99 | Price 18.10 | Shares 3,828

Proposed sale 22 Jan 2026

Value US$64,961.16 | Price 16.97 | Shares 3,828

Hyep Ivan

Chief Financial Officer

2 sales — total 68,321 USD

Planned sale 22 Jan 2026

Value US$34,162.44 | Price 18.15 | Shares 1,882

Proposed sale 22 Jan 2026

Value US$34,158.30 | Price 18.15 | Shares 1,882

Cohlhepp Ryan

President and COO

2 sales — total 5,370 USD

Planned sale 15 Jan 2026

Value US$2,684.98 | Price 18.02 | Shares 149

Proposed sale 15 Jan 2026

Value US$2,684.98 | Price 18.02 | Shares 149

Hyep Ivan

Chief Financial Officer

2 sales — total 332,896 USD

Planned sale 22 Dec 2025

Value US$168,491.56 | Price 18.31 | Shares 9,200

Proposed sale 22 Dec 2025

Value US$164,404.00 | Price 17.87 | Shares 9,200

Cohlhepp Ryan

President and COO

3 sales — total 467,298 USD

Planned sale 15 Dec 2025

Value US$84,077.10 | Price 18.68 | Shares 4,500

Planned sale 15 Dec 2025

Value US$149,470.40 | Price 18.68 | Shares 8,000

Proposed sale 15 Dec 2025

Value US$233,750.00 | Price 18.70 | Shares 12,500

Raben David

Officer

3 sales — total 207,266 USD

Proposed sale 25 Nov 2025

Value US$103,633.11 | Price 18.84 | Shares 5,500

Planned sale 25 Nov 2025

Value US$17,071.21 | Price 18.84 | Shares 906

Planned sale 25 Nov 2025

Value US$86,561.99 | Price 18.84 | Shares 4,594

Raben David

Chief Medical Officer

1 sale — total 101,475 USD

Planned sale 24 Nov 2025

Value US$101,475.00 | Price 18.45 | Shares 5,500

Hyep Ivan

Chief Financial Officer

1 sale — total 330,094 USD

Planned sale 24 Nov 2025

Value US$330,093.69 | Price 18.55 | Shares 17,795

Mazumdar Claire

Chief Executive Officer

2 sales — total 1,552,858 USD

Planned sale 24 Nov 2025

Value US$776,428.85 | Price 18.86 | Shares 41,163

Proposed sale 24 Nov 2025

Value US$776,428.85 | Price 18.86 | Shares 41,163

Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other

Notification date	Transaction date	B/S Transaction type	Insider and/or position	Nb. shares Price Value	Number of shares	Price	Value
2026-06-25	2026-06-25	PrS Proposed sale	DAVID RABEN Officer Officer	81,443 51.92 US$3,741,157	81,443	51.92	US$3,741,157
2026-06-01	2026-06-01	PrS Proposed sale	3.5 Meisner Lara Former Chief Legal Officer Officer	64,736 167.27 US$3,500,364	64,736	167.27	US$3,500,364
2026-05-26	2026-05-26	PrS Proposed sale	Raben David Officer Officer	7,497 179.01 US$2,382,810	7,497	179.01	US$2,382,810
2026-05-26	2026-05-21	PlS Planned sale	Hyep Ivan Chief Financial Officer Officer	9,200 -6.0% 20.42 US$187,883	9,200 -6.0%	20.42	US$187,883
2026-05-21	2026-05-21	PrS Proposed sale	Hyep Ivan Officer Officer	9,200 20.42 US$187,883	9,200	20.42	US$187,883
2026-05-20	2026-05-18	PlS Planned sale	Mazumdar Claire Chief Executive Officer Executive Director	2,978 -0.8% 20.35 US$60,597	2,978 -0.8%	20.35	US$60,597
2026-05-20	2026-05-18	PlS Planned sale	Mazumdar Claire Chief Executive Officer Executive Director	12,022 -3.2% 19.96 US$239,982	12,022 -3.2%	19.96	US$239,982
2026-05-18	2026-05-18	PrS Proposed sale	Mazumdar Claire Officer; Director Executive Director	15,000 20.92 US$313,800	15,000	20.92	US$313,800
2026-05-18	2026-05-18	PrS Proposed sale	Mazumdar Claire Officer; Director Executive Director	15,000 20.92 US$313,800	15,000	20.92	US$313,800
2026-05-18	2026-05-15	PlS Planned sale	Cohlhepp Ryan President and COO Executive Director	4,500 -2.3% 20.29 US$91,314	4,500 -2.3%	20.29	US$91,314
2026-05-18	2026-05-15	PlS Planned sale	Cohlhepp Ryan President and COO Executive Director	8,000 -3.9% 20.29 US$162,335	8,000 -3.9%	20.29	US$162,335
2026-05-15	2026-05-15	PrS Proposed sale	Cohlhepp Ryan Officer; Director Executive Director	12,500 20.31 US$253,875	12,500	20.31	US$253,875
2026-04-28	2026-04-27	PlS Planned sale	Raben David Chief Medical Officer Officer	5,500 -9.0% 22.88 US$125,830	5,500 -9.0%	22.88	US$125,830
2026-04-27	2026-04-27	PrS Proposed sale	Raben David Officer Officer	5,500 22.88 US$125,830	5,500	22.88	US$125,830
2026-04-22	2026-04-21	PlS Planned sale	Hyep Ivan Chief Financial Officer Officer	9,200 -6.0% 23.00 US$211,614	9,200 -6.0%	23.00	US$211,614
2026-04-21	2026-04-21	PrS Proposed sale	Hyep Ivan Officer Officer	9,200 23.18 US$213,210	9,200	23.18	US$213,210
2026-04-20	2026-04-20	PlS Planned sale	Mazumdar Claire Chief Executive Officer Executive Director	15,000 -4.0% 23.61 US$354,146	15,000 -4.0%	23.61	US$354,146
2026-04-20	2026-04-20	PrS Proposed sale	Mazumdar Claire Officer; Director Executive Director	15,000 23.74 US$356,100	15,000	23.74	US$356,100
2026-04-17	2026-04-15	PlS Planned sale	Cohlhepp Ryan President and COO Executive Director	4,500 -2.2% 23.01 US$103,533	4,500 -2.2%	23.01	US$103,533
2026-04-17	2026-04-15	PlS Planned sale	Cohlhepp Ryan President and COO Executive Director	8,000 -3.8% 23.01 US$184,058	8,000 -3.8%	23.01	US$184,058
2026-04-15	2026-04-15	PrS Proposed sale	Cohlhepp Ryan Officer; Director Executive Director	12,500 22.98 US$287,250	12,500	22.98	US$287,250
2026-03-26	2026-03-25	PlS Planned sale	Raben David Chief Medical Officer Officer	5,500 -9.0% 18.95 US$104,229	5,500 -9.0%	18.95	US$104,229
2026-03-25	2026-03-25	PrS Proposed sale	Raben David Officer Officer	5,500 18.95 US$104,229	5,500	18.95	US$104,229
2026-03-24	2026-03-23	PlS Planned sale	Hyep Ivan Chief Financial Officer Officer	9,200 -6.0% 18.52 US$170,348	9,200 -6.0%	18.52	US$170,348
2026-03-23	2026-03-23	PrS Proposed sale	Hyep Ivan Officer Officer	9,200 18.60 US$171,120	9,200	18.60	US$171,120
2026-03-20	2026-03-20	PlS Planned sale	Mazumdar Claire Chief Executive Officer Executive Director	1,596 -0.5% 18.95 US$30,246	1,596 -0.5%	18.95	US$30,246
2026-03-20	2026-03-20	PrS Proposed sale	Mazumdar Claire Officer; Director Executive Director	1,596 18.95 US$30,246	1,596	18.95	US$30,246
2026-03-20	2026-03-19	PlS Planned sale	Mazumdar Claire Chief Executive Officer Executive Director	6,905 -2.0% 18.78 US$129,705	6,905 -2.0%	18.78	US$129,705
2026-03-19	2026-03-19	PrS Proposed sale	Mazumdar Claire Officer; Director Executive Director	6,905 18.78 US$129,705	6,905	18.78	US$129,705
2026-03-20	2026-03-18	PlS Planned sale	Mazumdar Claire Chief Executive Officer Executive Director	6,499 -1.9% 18.84 US$122,415	6,499 -1.9%	18.84	US$122,415
2026-03-18	2026-03-18	PrS Proposed sale	Mazumdar Claire Officer; Director Executive Director	6,499 19.19 US$124,716	6,499	19.19	US$124,716
2026-03-17	2026-03-16	PlS Planned sale	Cohlhepp Ryan President and COO Executive Director	4,500 -2.2% 19.66 US$88,457	4,500 -2.2%	19.66	US$88,457
2026-03-17	2026-03-16	PlS Planned sale	Cohlhepp Ryan President and COO Executive Director	8,000 -3.8% 19.66 US$157,257	8,000 -3.8%	19.66	US$157,257
2026-03-16	2026-03-16	PrS Proposed sale	Cohlhepp Ryan Officer; Director Executive Director	12,500 19.34 US$241,750	12,500	19.34	US$241,750
2026-03-11	2026-03-09	PlS Planned sale	Mazumdar Claire Chief Executive Officer Executive Director	36,766 -9.8% 19.17 US$704,657	36,766 -9.8%	19.17	US$704,657
2026-03-09	2026-03-09	PrS Proposed sale	Mazumdar Claire Officer Officer	36,766 19.17 US$704,657	36,766	19.17	US$704,657
2026-03-06	2026-03-06	PlS Planned sale	Mazumdar Claire Chief Executive Officer Executive Director	3,817 -1.1% 18.75 US$71,572	3,817 -1.1%	18.75	US$71,572
2026-03-06	2026-03-06	PrS Proposed sale	Mazumdar Claire Officer Officer	3,817 19.80 US$75,572	3,817	19.80	US$75,572
2026-03-06	2026-03-05	PlS Planned sale	Mazumdar Claire Chief Executive Officer Executive Director	1,786 -0.5% 18.74 US$33,464	1,786 -0.5%	18.74	US$33,464
2026-03-05	2026-03-05	PrS Proposed sale	Mazumdar Claire Officer Officer	1,786 18.74 US$33,464	1,786	18.74	US$33,464
2026-03-06	2026-03-04	PlS Planned sale	Mazumdar Claire Chief Executive Officer Executive Director	2,631 -0.8% 18.73 US$49,289	2,631 -0.8%	18.73	US$49,289
2026-03-05	2026-03-04	PlS Planned sale	Hyep Ivan Chief Financial Officer Officer	2,963 -2.0% 18.25 US$54,062	2,963 -2.0%	18.25	US$54,062
2026-03-05	2026-03-04	PlS Planned sale	Raben David Chief Medical Officer Officer	16,300 -22.8% 18.52 US$301,920	16,300 -22.8%	18.52	US$301,920
2026-03-04	2026-03-04	PrS Proposed sale	Hyep Ivan Officer Officer	2,963 18.25 US$54,062	2,963	18.25	US$54,062
2026-03-04	2026-03-04	PrS Proposed sale	Mazumdar Claire Officer Officer	2,631 18.73 US$49,289	2,631	18.73	US$49,289
2026-03-04	2026-03-04	PrS Proposed sale	Raben David Officer Officer	16,300 18.52 US$301,920	16,300	18.52	US$301,920
2026-03-05	2026-03-03	PlS Planned sale	Cohlhepp Ryan President and COO Executive Director	4,500 -2.1% 18.16 US$81,734	4,500 -2.1%	18.16	US$81,734
2026-03-05	2026-03-03	PlS Planned sale	Cohlhepp Ryan President and COO Executive Director	12,892 -5.8% 18.16 US$234,159	12,892 -5.8%	18.16	US$234,159
2026-03-05	2026-03-03	PlS Planned sale	Hyep Ivan Chief Financial Officer Officer	13,555 -8.5% 18.22 US$246,910	13,555 -8.5%	18.22	US$246,910
2026-03-05	2026-03-03	PlS Planned sale	Raben David Chief Medical Officer Officer	200 -0.4% 18.45 US$3,690	200 -0.4%	18.45	US$3,690
2026-03-03	2026-03-03	PrS Proposed sale	Hyep Ivan Officer Officer	13,555 18.22 US$246,910	13,555	18.22	US$246,910
2026-03-03	2026-03-03	PrS Proposed sale	Raben David Officer Officer	200 18.45 US$3,690	200	18.45	US$3,690
2026-03-03	2026-03-03	PrS Proposed sale	Cohlhepp Ryan Officer Officer	17,392 18.16 US$315,893	17,392	18.16	US$315,893
2026-03-02	2026-02-26	B Purchase	2.9 RA CAPITAL MANAGEMENT, L.P. Non-Executive Director Large shareholder	300,000 +7.0% 16.00 US$4,800,000	300,000 +7.0%	16.00	US$4,800,000
2026-02-27	2026-02-25	PlS Planned sale	Cohlhepp Ryan President and COO Executive Director	523 -0.2% 18.04 US$9,435	523 -0.2%	18.04	US$9,435
2026-02-27	2026-02-25	PlS Planned sale	Cohlhepp Ryan President and COO Executive Director	3,108 -1.5% 18.04 US$56,067	3,108 -1.5%	18.04	US$56,067
2026-02-25	2026-02-25	PrS Proposed sale	Cohlhepp Ryan Officer Officer	3,631 18.04 US$65,501	3,631	18.04	US$65,501
2026-01-26	2026-01-22	PlS Planned sale	Cohlhepp Ryan President and COO Executive Director	3,828 -1.8% 18.10 US$69,296	3,828 -1.8%	18.10	US$69,296
2026-01-26	2026-01-22	PlS Planned sale	Hyep Ivan Chief Financial Officer Officer	1,882 -1.3% 18.15 US$34,162	1,882 -1.3%	18.15	US$34,162
2026-01-22	2026-01-22	PrS Proposed sale	Cohlhepp Ryan Officer Officer	3,828 16.97 US$64,961	3,828	16.97	US$64,961
2026-01-22	2026-01-22	PrS Proposed sale	Hyep Ivan Officer Officer	1,882 18.15 US$34,158	1,882	18.15	US$34,158
2026-01-20	2026-01-15	PlS Planned sale	Cohlhepp Ryan President and COO Executive Director	149 -0.1% 18.02 US$2,685	149 -0.1%	18.02	US$2,685
2026-01-15	2026-01-15	PrS Proposed sale	Cohlhepp Ryan Officer Officer	149 18.02 US$2,685	149	18.02	US$2,685
2025-12-23	2025-12-22	PlS Planned sale	Hyep Ivan Chief Financial Officer Officer	9,200 -6.0% 18.31 US$168,492	9,200 -6.0%	18.31	US$168,492
2025-12-22	2025-12-22	PrS Proposed sale	Hyep Ivan Officer Officer	9,200 17.87 US$164,404	9,200	17.87	US$164,404
2025-12-16	2025-12-15	PlS Planned sale	Cohlhepp Ryan President and COO Executive Director	4,500 -2.3% 18.68 US$84,077	4,500 -2.3%	18.68	US$84,077
2025-12-16	2025-12-15	PlS Planned sale	Cohlhepp Ryan President and COO Executive Director	8,000 -4.0% 18.68 US$149,470	8,000 -4.0%	18.68	US$149,470
2025-12-15	2025-12-15	PrS Proposed sale	Cohlhepp Ryan Officer Officer	12,500 18.70 US$233,750	12,500	18.70	US$233,750
2025-11-25	2025-11-25	PrS Proposed sale	Raben David Officer Officer	5,500 18.84 US$103,633	5,500	18.84	US$103,633
2025-11-25	2025-11-25	PlS Planned sale	Raben David Chief Medical Officer Officer	906 -2.5% 18.84 US$17,071	906 -2.5%	18.84	US$17,071
2025-11-25	2025-11-25	PlS Planned sale	Raben David Chief Medical Officer Officer	4,594 -11.5% 18.84 US$86,562	4,594 -11.5%	18.84	US$86,562
2025-11-25	2025-11-24	PlS Planned sale	Raben David Chief Medical Officer Officer	5,500 -13.4% 18.45 US$101,475	5,500 -13.4%	18.45	US$101,475
2025-11-25	2025-11-24	PlS Planned sale	Hyep Ivan Chief Financial Officer Officer	17,795 -10.9% 18.55 US$330,094	17,795 -10.9%	18.55	US$330,094
2025-11-25	2025-11-24	PlS Planned sale	Mazumdar Claire Chief Executive Officer Executive Director	41,163 -11.7% 18.86 US$776,429	41,163 -11.7%	18.86	US$776,429
2025-11-24	2025-11-24	PrS Proposed sale	Mazumdar Claire Officer Officer	41,163 18.86 US$776,429	41,163	18.86	US$776,429

Explore more

More insider trading research around Bicara Therapeutics Inc

More insider trades in United States

Similar Healthcare companies with insider activity

More Pharmaceuticals & Medical Research companies with insider activity

More Biotechnology & Medical Research companies with insider activity

Insider trading in North America

Bicara Therapeutics Inc (BCAX)

Track

Featured in screeners

Stock chart

Transactions

Insider

Sort by

Trades

Explore more